Biotechnology

Biogen Board Proposes Annual Election Of Directors

Genzyme Says In Talks To Bring R&D To Russia

French Drugmaker Sanofi-Aventis SA Reaches Finall Agreement to Buy Genzyme Corp

Sanofi-Aventis SA has agreed in principle to acquire Genzyme Corp for $19.2 billion in cash

Novozymes to Buy EMD/Merck Crop BioScience

Amylopectin Starch Potatoes: Avebe and BASF Plant Science Cooperate

Spain Sets Out Plan To Boost Industry

Severin Schwan of Roche Sees Generic Companies and Innovators As Winners

Merck Set to Buy Biotech Firm SmartCells

Genmab CEO Worried By Takeover Risk

Genzyme, Sanofi at Odds Over Threshold Price

U.S. Proposes Wide Changes in Role Fighting Disease

White Knight Could Be Elusive For Genzyme

Genzyme Weighs Sanofi Approach, Not Keen to Sell

Topics • Technology

Building For Generations

BASF Plant Science, Monsanto to Expand Collaboration in Maximizing Crop Yield

Pharming Signs Manufacturing Deal with Sanofi-Aventis

Sanofi Declines Comment on U.S. Deal

Sanofi Buys TargeGen to Boost Cancer Treatments

Amgen CEO Looking for International Acquisitions

Merck to Seek 5 New Drug Approvals This Year

AstraZeneca Sees More Deals to Fill Out Pipeline

Amgen Promotes Bradway to CEO

Sanofi to Invest $200 Million in French Biotech Plants

'A Merger For Growth'

Is Merck KGaA's $6 Billion Bid for Millipore Too Costly?

Update: Merck KGaA Buys Millipore to Stabilize Business

Germany's Merck to Buy Millipore in $6 Billion Deal

Millipore Says Evaluating ‘Strategic Alternatives’

Thermo Fisher in $6 Billion Bid for Millipore

Linked Together

Topics • Technology

Biotech: A Major Contributor to  Pharma Global Business

Topics • Technology

Closing The Gap

Top-Feature

Predictive Simulation in Pharma Production

CHEManager International c/o Wiley-VCH GmbH

Event Sponsorship: Next Generation Batteries and Hydrogen

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Article

The State of the US Specialty Chemicals Industry

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Jan Ramakers Fine Chemical

Alira Health S.r.l.

Primogene GmbH

Ontario Int. Marketing Ct.

SchüllerConsulting

ACIB Austrian Centre of Industrial Biotechnology

Jennewein Biotechnologie GmbH

GEA Liquid Processing

Groupe Novasep

Wacker Chemie

GETEC Group

Dechema e.V.

Managm. Consult. Chemicals

CzechInvest

Simon-Kucher & Partners Strategy & Marketing Consultants GmbH

Berlin Partner für Wirtschaft und Technologie GmbH

Millipore Corporation

Rentschler Biopharma SE

Kaye Scholer

Germany Trade & Invest

Evonik Industries AG

Olon S.p.A.

BCNP Consultants GmbH

SK Pharmteco

EvaluatePharma

Novozymes Biopharma UK Ltd.

Farmindustria

Tufts University

Henkel AG & Co. KGaA

Thomson Reuters

Federchimica

Bio Consortia

International Sustainable Chemistry Collaborative Centre ISC3

Enamine Ltd.

Hamilton AG

BioCampus Straubing

Arthur D. Little